From the Division of Addiction Medicine, Boston Children's Hospital, Boston, MA (SL, MM, MB, ERW); Department of Pediatrics, Harvard Medical School, Boston, MA (SL, ERW); Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, Boston, MA (ERW); The National Institute on Drug Abuse, Rockville, MD (GS); The Emmes Company, Rockville, MD (JM); Division of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, MA (RW); Department of Psychiatry, Harvard Medical School, Boston, MA (RW); and Computational Health Informatics Program, Boston Children's Hospital, Boston, MA (ERW).
J Addict Med. 2024;18(2):205-208. doi: 10.1097/ADM.0000000000001271. Epub 2024 Jan 30.
The World Mental Health Composite International Diagnostic Interview Substance Abuse Module (WMH-CIDI-SAM) is commonly used as a criterion standard measure for substance use disorder (SUD) diagnoses, although the accuracy of this tool when used with adolescents is unknown. The objective of this study was to evaluate the agreement between SUD diagnoses for adolescents made by WMH-CIDI-SAM and those made by specialists based on Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) ( DSM-5 ) SUD criteria during an SUD evaluation.
Adolescents aged 12 to 17 years presenting to an outpatient SUD program for youth were administered the WMH-CIDI-SAM by a trained research assistant, and results were compared with diagnoses made by experienced clinicians based on DSM-5 SUD criteria during an initial SUD evaluation. Chance-corrected concordance was estimated using the κ coefficient for the comparisons.
The level of concordance between the WMH-CIDI-SAM interview and the clinician diagnosis based on DSM-5 SUD criteria were fair to moderate for alcohol use disorder and tobacco use disorder and poor for cannabis use disorder. Three of 11 WMH-CIDI-SAM item constructs showed poor concordance with clinician diagnosis.
Interpreting the diagnostic criteria for SUDs, particularly cannabis use disorders, is nuanced, and the meaning of the criteria may be misunderstood by adolescents. Further evaluation of the performance of the WMH-CIDI-SAM diagnostic interview for identifying cannabis use disorders in adolescents is needed.
世界心理健康综合国际诊断访谈物质滥用模块(WMH-CIDI-SAM)通常被用作物质使用障碍(SUD)诊断的标准衡量标准,尽管其在青少年中使用的准确性尚不清楚。本研究的目的是评估青少年 SUD 诊断的一致性,即 WMH-CIDI-SAM 与根据精神障碍诊断与统计手册(第五版)(DSM-5)SUD 标准由专家在 SUD 评估中做出的诊断。
12 至 17 岁的青少年在青少年门诊 SUD 计划中就诊,由经过培训的研究助理进行 WMH-CIDI-SAM 评估,结果与经验丰富的临床医生根据 DSM-5 SUD 标准在初始 SUD 评估中做出的诊断进行比较。使用κ系数估计比较的校正机会一致性。
WMH-CIDI-SAM 访谈与基于 DSM-5 SUD 标准的临床医生诊断之间的一致性水平对于酒精使用障碍和烟草使用障碍为中等至良好,对于大麻使用障碍则较差。WMH-CIDI-SAM 的 11 个项目结构中有 3 个与临床医生诊断的一致性较差。
解释 SUD 的诊断标准,特别是大麻使用障碍,需要细致入微,青少年可能会误解标准的含义。需要进一步评估 WMH-CIDI-SAM 诊断访谈在识别青少年大麻使用障碍方面的性能。